Genome & Company (KOSDAQ:314130)
2,670.00
+65.00 (2.50%)
At close: Aug 4, 2025, 3:30 PM KST
Squarespace Market Cap
Genome & Company has a market cap or net worth of 81.29 billion as of August 8, 2025. Its market cap has decreased by -34.18% in one year.
Market Cap
81.29B
Enterprise Value
87.28B
Revenue
29.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
$2,670.00
Market Cap Chart
Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 81.29B, an increase of 13.09%. That is a compound annual growth rate of 1.88%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 81.29B | -4.60% |
Dec 30, 2024 | 85.21B | -51.64% |
Dec 28, 2023 | 176.21B | -28.34% |
Dec 29, 2022 | 245.90B | -47.55% |
Dec 30, 2021 | 468.83B | -55.28% |
Dec 30, 2020 | 1,048.46B | 224.28% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 457.00T |
SK hynix | 181.91T |
LG Energy Solution | 90.44T |
Samsung Biologics | 74.80T |
Hanwha Aerospace | 49.44T |
Hyundai Motor Company | 45.99T |
Doosan Enerbility | 41.50T |
HD Hyundai Heavy Industries | 41.19T |